Canadian Cancer Trials Group Bulletins

Trial Management Group

Trial Closed to Accrual

We are pleased to announce that Canadian Cancer Trials Group MA.33/TROG 07.01 - A Randomized Phase III Study of Radiation Doses and Fractionation Schedules for Ductal Carcinoma in Situ of the Breast - was closed to further accrual on June 20, 2014.

This trial has met its accrual goal and Canadian sites enrolled 300/1600 patients (18.8%). All Canadian patients will have completed protocol treatment by August 15, 2014.

Thank you to everyone who has worked on this trial and to the patients who participated.